Monte Rosa Therapeutics, Inc.

NASDAQ (USD): Monte Rosa Therapeutics, Inc. (GLUE)

Last Price

9.48

Today's Change

+4.59 (93.86%)

Day's Change

6.16 - 12.40

Trading Volume

94,666,959

Overview

Market Cap

581 Million

Shares Outstanding

61 Million

Avg Volume

349,351

Avg Price (50 Days)

5.62

Avg Price (200 Days)

5.30

PE Ratio

-4.27

EPS

-2.22

Earnings Announcement

07-Nov-2024

Previous Close

4.89

Open

6.39

Day's Range

6.16 - 12.4

Year Range

2.765 - 12.4

Trading Volume

94,850,892

Price Change Highlight

1 Day Change

93.86%

5 Day Change

80.23%

1 Month Change

83.37%

3 Month Change

103.00%

6 Month Change

77.86%

Ytd Change

66.02%

1 Year Change

205.81%

3 Year Change

-65.08%

5 Year Change

-55.24%

10 Year Change

-55.24%

Max Change

-55.24%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of inflammatory diseases, such as Crohn's disease, neurodegenerative disease, diabetes, and liver disease; VAV1, a target protein for autoimmune diseases; and BCL11A, a therapeutically-relevant protein in hemoglobinopathies. Monte Rosa Therapeutics, Inc. was incorporated in 2019 and is headquartered in Boston, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment